Largest pharmaceuticals by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 35 pharmaceuticals ranked by total debt, at $67.5B, ahead of Pfizer ($64.8B) and Merck & Co ($49.3B). Figures as of 17 Nov 2026, 17:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
35
First
AbbVie$67.5B
Median
$5.3B
Combined market value
$5.17T
Countries
10
Not ranked
26no total debt on file

Market values as of .

Largest pharmaceuticals by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health Care$67.5B$518.2B$293.17 0.47% down 26% up United States
2PfizerPFE · Health Care$64.8B$162.7B$28.54 1.11% down 13% up United States
3Merck & CoMRK · Health Care$49.3B$354.9B$143.98 0.33% down 50% up United States
4Johnson & JohnsonJNJ · Health Care$47.9B$675.4B$280.57 0.70% down 41% up United States
5Bristol-Myers SquibbBMY · Health Care$45.1B$124.5B$60.93 3.19% down 34% up United States
6Eli LillyLLY · Health Care$42.5B$1.26T$1,416.29 1.07% down 39% up United States
7Takeda PharmaceuticalTAK · Health Care$30.6B$69.4B$21.71 0.56% up 53% up Japan
8AstraZenecaAZN · Health Care$29.6B$284.4B$183.39 0.34% down 3% up United Kingdom
9NovartisNVS · Health Care$28.7B$301.9B$159.86 0.21% down 25% up Switzerland
10SanofiSNY · Health Care$20.8B$115.1B$47.93 0.96% down 4% down France
11Novo NordiskNVO · Health Care$19.4B$179.3B$40.69 2.18% down 13% down Denmark
12GSKGSK · Health Care$19.2B$99.2B$49.49 1.83% down 6% up United Kingdom
13ViatrisVTRS · Health Care$14.4B$23.7B$20.63 0.53% down 94% up United States
14Abbott LaboratoriesABT · Health Care$12.9B$184B$106.24 1.13% down 17% down United States
15ZoetisZTS · Health Care$9B$34.1B$83.85 0.64% down 29% down United States
16Royalty PharmaRPRX · Health Care$9B$39.3B$68.35 0.26% down 74% up United States
17Jazz PharmaceuticalsJAZZ · Health Care$5.4B$15.6B$242.34 1.07% up 33% up Ireland
18GenmabGMAB · Health Care$5.3B$31.9B$51.80 0.45% up 70% up Denmark
19Elanco Animal HealthELAN · Health Care$4B$13B$26.06 1.33% down 23% up United States
20Amneal PharmaceuticalsAMRX · Health Care$2.6B$7.3B$21.08 0.71% down 83% up United States
21BridgeBio PharmaBBIO · Health Care$2B$14.9B$76.63 0.94% down 18% up United States
22Regeneron PharmaceuticalsREGN · Health Care$2B$99.5B$961.54 0.96% up 31% up United States
23Ionis PharmaceuticalsIONS · Health Care$1.8B$4.5B$27.05 3.43% down 62% down United States
24BeOne MedicinesONC · Health Care$1B$46.9B$410.40 0.22% down 13% up Switzerland
25Ascendis PharmaASND · Health Care$799.1M$17.5B$267.14 1.69% down 25% up Denmark
26InsmedINSM · Health Care$546.8M$26.3B$119.75 2.55% down 39% down United States
27Madrigal PharmaceuticalsMDGL · Health Care$339.9M$9.9B$426.93 0.70% up 24% down United States
28Legend BiotechLEGN · Health Care$319.1M$3.2B$16.27 1.75% up 46% down United States
29CytokineticsCYTK · Health Care$287.6M$7.2B$51.87 2.44% down 20% down United States
30TG TherapeuticsTGTX · Health Care$245.6M$9.5B$62.88 0.19% up 101% up United States
31Cogent BiosciencesCOGT · Health Care$222.9M$4.7B$26.98 1.68% down 18% down United States
32Dr. Reddy's LaboratoriesRDY · Health Care$193.7M$12.4B$14.89 1.29% up 5% up India
33Axsome TherapeuticsAXSM · Health Care$187.7M$7.2B$136.72 0.21% down 7% down United States
34Rhythm PharmaceuticalsRYTM · Health Care$108.2M$7.9B$113.72 5.80% up 7% up United States
35Definium TherapeuticsDFTX · Health Care$40.6M$4B$29.36 2.64% down 164% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. 26 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceuticals rank first by total debt?

AbbVie ($67.5B), Pfizer ($64.8B) and Merck & Co ($49.3B) are the top three of the 35 pharmaceuticals ranked by total debt as of 17 Nov 2026, 17:20 UTC.

How many pharmaceuticals are in this ranking?

35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

Their combined market value is $5.17T as of 17 Nov 2026, 17:20 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceuticals by total debt”, data as of 17 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.